Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
The latest update is out from China Tianbao Group Development Company Limited ( (HK:1427) ).
China Tianbao Group Development Company Limited has appointed Ms. Chen Zhu as an independent non-executive director with effect from 21 January 2026, strengthening its board with a senior executive who brings more than three decades of hospital management and healthcare industry experience in mainland China, including leadership roles in military hospitals, the Chinese PLA General Hospital and private healthcare and medical technology enterprises. Ms. Chen will serve until October 2028 under a letter of appointment that provides for an annual director’s fee of US$20,000 and subjects her to shareholder approval and standard rotation and re-election procedures, with the company emphasizing her compliance with Hong Kong’s independence criteria and signalling a continued focus on enhancing board independence and governance oversight for stakeholders.
The most recent analyst rating on (HK:1427) stock is a Hold with a HK$0.23 price target. To see the full list of analyst forecasts on China Tianbao Group Development Company Limited stock, see the HK:1427 Stock Forecast page.
More about China Tianbao Group Development Company Limited
China Tianbao Group Development Company Limited is a Hong Kong-listed company incorporated in the Cayman Islands, with its shares traded on the Main Board of the Stock Exchange of Hong Kong under stock code 1427. The group operates under a board structure that includes independent non-executive directors and various specialized board committees in line with Hong Kong Listing Rules and corporate governance requirements.
Average Trading Volume: 41,222
Technical Sentiment Signal: Buy
Current Market Cap: HK$207.2M
See more data about 1427 stock on TipRanks’ Stock Analysis page.